INVIVO THERAPEUTICS HOLDINGS (NVIV)
US46186M6057 - Common Stock
| TTM (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -9.33M | -10.49M | -9.90M | -9.07M | -11.83M | |||
| Depreciation Amortization | 50.00K | 60.00K | 40.00K | 50.00K | 60.00K | |||
| Change In Working Capital | -1.41M | -600.00K | 350.00K | -1.00M | 260.00K | |||
| Interest Paid | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Taxes Paid | N/A | N/A | 0.00 | N/A | N/A | |||
| Other non cash items | 550.00K | 540.00K | 640.00K | 500.00K | 1.20M | |||
| OPERATING CASH FLOW | -10.13M | -10.48M | -8.85M | -9.53M | -10.31M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -50.00K | -160.00K | -80.00K | -40.00K | -10.00K | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | 50.00K | -160.00K | -80.00K | -40.00K | -10.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | -100.00K | |||
| Stock Issued/Repurchased | N/A | 7.96M | 8.51M | 22.46M | 370.00K | |||
| FINANCING CASH FLOW | N/A | 7.96M | 8.51M | 22.46M | 270.00K | |||
| CHANGE IN CASH | -2.12M | -2.68M | -420.00K | 12.89M | -10.05M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -10.13M | -10.48M | -8.85M | -9.53M | -10.31M | |||
| Capital Expenditure | -50.00K | -160.00K | -80.00K | -40.00K | -10.00K | |||
| FREE CASH FLOW | -10.18M | -10.64M | -8.93M | -9.57M | -10.32M | |||
All data in USD